COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,198 Articles (22,713 medRxiv, 8,485 bioRxiv)

Most recent first Previous |  Page 2023: Articles 20221-20230  | Next

Autosomal Dominant Polycystic Kidney Disease does not significantly alter major COVID-19 outcomes among veterans
Cui, X., Gallini, J. W., Jasien, C. L., Mrug, M.
10.1101/2020.11.25.20238675 — Posted: 2020-11-29
The psychosocial impact on frontline health and social care professionals in the UK during the COVID-19 pandemic: a qualitative interview study.
Aughterson, H., Mckinlay, A., Fancourt, D., Burton, A.
10.1101/2020.11.25.20238766 — Posted: 2020-11-29
Self-harm during the early period of the COVID-19 Pandemic in England: comparative trend analysis of hospital presentations
Hawton, K., Casey, D., Bale, E., Brand, F., Ness, J., Waters, K., Kelly, S., Guelayov, G.
10.1101/2020.11.25.20238030 — Posted: 2020-11-29
Performance of prediction models for short term outcome in COVID-19 patients in the emergency department: a retrospective study
van Dam, P. M. E. L., Zelis, N., van Kuijk, S. M. J., Linkens, A. E. M. J. H., Bruggemann, R. R. A. G., Spaetgens, B., van der Horst, I. C. C., Stassen, P. M.
10.1101/2020.11.25.20238527 — Posted: 2020-11-29
Dental practice in Pre- COVID19 and Future Perspectives
Subramanya, A. P., MLV, P.
10.1101/2020.11.24.20238303 — Posted: 2020-11-29
A Test-Based Strategy for Safely Shortening Quarantine for COVID-19
Lewis, D., Leibrand, S., Leibrand, H.
10.1101/2020.11.24.20238287 — Posted: 2020-11-29
Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
Ray, Y., Paul, S. R., Bandopadhyay, P., D'Rozario, R., Sarif, J., Lahiri, A., Bhowmik, D., Vasudevan, J. S., Maurya, R., Kanakan, A., Sharma, S., Kumar, M., Singh, P., Roy, R., Chaudhury, K., Maiti, R., Bagchi, S., Maiti, A., Perwez, M. M., Mondal, A., Tewari, A., Mandal, S., Roy, A., Saha, M., Biswas, D., Maiti, C., Chakraborty, S., Sharma Sarkar, B., Haldar, A., Saha, B., Sengupta, S., Pandey, R., Chatterjee, S., Bhattacharya, P., Paul, S., Ganguly, D.
10.1101/2020.11.25.20237883 — Posted: 2020-11-29
A double-edged sword - Telemedicine for maternal care during COVID-19: Findings from a global mixed methods study of healthcare providers
Galle, A., Semaan, A., Huysmans, E., Audet, C., Asefa, A., Delvaux, T., Afolabi, B. B., El Ayadi, A., Benova, L.
10.1101/2020.11.25.20238535 — Posted: 2020-11-29
County Demographics and COVID-19 Death Rates: Comparison of relationship in the first and current stage of the pandemic in the United States of America
Urbine, E., James, M., Shah, V.
10.1101/2020.11.24.20237818 — Posted: 2020-11-28
Body mass index and risk of COVID-19 diagnosis, hospitalisation, and death: a population-based multi-state cohort analysis including 2,524,926 people in Catalonia, Spain
Recalde, M., Pistillo, A., Fernandez-Bertolin, S., Roel, E., Aragon, M., Freisling, H., Prieto-Alhambra, D., Burn, E., Duarte-Salles, T.
10.1101/2020.11.25.20237776 — Posted: 2020-11-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).